vTv Therapeutics (VTVT) Non-Current Deffered Revenue (2017 - 2026)
vTv Therapeutics' Non-Current Deffered Revenue was $1.83 million in Q2 2026, down 90.2% from $18.67 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at vTv Therapeutics came in at $18.67 million, unchanged from FY2024.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 79.2% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $18.67 million in FY2024 (unchanged), $18.67 million in FY2023 (unchanged) and $18.67 million in FY2022.
- Quarterly Non-Current Deffered Revenue has moved between $9,000 (Q3 2021) and $18.67 million (Q4 2025) over five years.
- Across the past five years, year-over-year decline in Non-Current Deffered Revenue ran from 0.0% in Q4 2025 to 99.1% in Q3 2021.
- Per Business Quant data, VTVT's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $1.83 million (Q1 2026), $18.67 million (Q4 2025) and $18.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | vTv Therapeutics | 395.24 Mn | 395.24 Mn | - | 1.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 18.67 Mn |
| Jun 30, 2025 | 18.67 Mn |
| Mar 31, 2025 | 18.67 Mn |
| Dec 31, 2024 | 18.67 Mn |
| Sep 30, 2024 | 18.67 Mn |
| Jun 30, 2024 | 18.67 Mn |
| Mar 31, 2024 | 18.67 Mn |
| Dec 31, 2023 | 18.67 Mn |
| Sep 30, 2023 | 18.67 Mn |
| Jun 30, 2023 | 18.67 Mn |
| Mar 31, 2023 | 18.67 Mn |
| Dec 31, 2022 | 18.67 Mn |
| Sep 30, 2022 | 18.67 Mn |
| Jun 30, 2022 | 18.67 Mn |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 18,000.00 |
API Access
vTv Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();